RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Acceptability of the dapivirine vaginal ring and daily oral pre-exposure prophylaxis (PrEP) during pregnancy in Malawi, South Africa, Uganda, and Zimbabwe
Young, A. M., Stoner, M., Mathebula, F., Mohuba, R., Baez, A. B., Seyama, L., Mutero, P., Etima, J., Fabiano, Z., Fairlie, L., Mayo, A., Balkus, J. E., Song, M., Bunge, K., Piper, J. M., Balan, I., Van Der Straten, A., & Montgomery, E. T. (2024). Acceptability of the dapivirine vaginal ring and daily oral pre-exposure prophylaxis (PrEP) during pregnancy in Malawi, South Africa, Uganda, and Zimbabwe. AIDS and Behavior. Advance online publication. https://doi.org/10.1007/s10461-024-04421-z